Alternatively spliced CS-1 fibronectin isoform and its receptor VLA-4 in rheumatoid arthritis synovium

Journal of Rheumatology

Volumn 24, Issue 10, 1997, Pages 1873-1880

  Müller Ladner, Ulf ^a   Elices, Mariano J ^d   Kriegsmann, Jörg B ^c   Strahl, Dana ^b   Gay, Renate E ^d   Firestein, Gary S ^f   Gay, Steffen ^e  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b CYTEL CORPORATION   (United States)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d Department of Medicine ^*

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f UCSD MEDICAL CENTER   (United States)

Author keywords

Connecting segment 1; Fibroblasts; Fibronectin; Macrophages; Rheumatoid arthritis; Very late antigen 4

Indexed keywords

BETA1 INTEGRIN; FIBRONECTIN;

ALTERNATIVE RNA SPLICING; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; FEMALE; FIBROBLAST; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; INFLAMMATORY INFILTRATE; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; RECEPTOR DENSITY; RHEUMATOID ARTHRITIS; SYNOVIUM;

ANTI-ALLERGIC AGENTS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ARTHRITIS, RHEUMATOID; CARRIER PROTEINS; CELLS, CULTURED; FEMALE; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTEGRIN ALPHA4BETA1; INTEGRINS; MACROPHAGES; MALE; OLIGOPEPTIDES; OSTEOARTHRITIS; RECEPTORS, LYMPHOCYTE HOMING; RNA, MESSENGER; SYNOVIAL MEMBRANE;

EID: 1842415406     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Gay S, Gay RE, Koopman WJ: Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: Two cellular mechanisms explain joint destruction. Ann Rheum Dis 1993;52:S39-47.
2. Fassbender HG: Histomorphologic basis of articular cartilage destruction in rheumatoid arthritis. Coll Relat Res 1983;3:141-55.
3. Harris ED: Rheumatoid arthritis: Pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
4. Firestein GS, Tsai V, Zvaifler NJ: Cellular immunity in the joints of patients with rheumatoid arthritis and other forms of chronic synovitis. Rheum Dis Clin N Am 1987;13:191-213.
5. Haskard DO: Adhesion molecules in rheumatoid arthritis. Curr Opin Rheumatol 1995;7:229-33.
6. Hynes RO: Fibronectins. New York: Springer, 1990.
7. Hemler ME: VLA proteins in the integrin family: Structures, functions, and their role on leukocytes. Annu Rev Immunol 1990;8:365-400.
8. Elices MJ: Leukocyte integrins. In: Integrins, Molecular and Biological Responses to the Extracellular Matrix. San Diego: Academic Press, 1994:163-94.
9. Lobb RR, Hemler HE: The pathophysiologic role of α4 integrins in vivo. J Clin Invest 1994;94:1722-8.
10. Kuijpers TW: Pathophysiological aspects of VLA-4 interactions and possibilities for therapeutical interventions. Springer Semin Immun 1995;16;379-89.
11. Elices MJ: The integrin α4ß1 (VLA-4) as a therapeutic target. In: Cell Adhesion and Human Disease. Ciba Foundation Symposium 189. Chichester: Wiley & Sons, 1995:79-90.
12. Elices MJ, Osborn L, Takada Y, et al: VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990;60:577-84.
13. Carlos TM, Schwart BR, Kovach NL, et al: Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood 1990;76:965-70.
14. Rice GE, Munro JM, Bevilacqua MP: Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes. (A CD11/CD18-independent adhesion mechanism.) J Exp Med 1990;171:1369-74.
15. Wayner EA, Garcia-Pardo A, Humphries MJ, McDonald JA, Carter WG: Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J Cell Biol 1989;109:1321-30.
16. Guan JL, Hynes RO: Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor α4ß1. Cell 1990;60:53-61.
17. Van Dinther-Janssen AC, Pals ST, Scheper RJ, Meijer CJ: Role of the CS-1 adhesion motif of fibronectin in T cell adhesion to synovial membrane and peripheral lymph node endothelium. Ann Rheum Dis 1993;52:672-6.
18. Makarem R, Newham P, Askari JA, et al: Competitive binding of vascular cell adhesion molecule-1 and the HepII/III CS domain of fibronectin to the integrin α4ß1. J Biol Chem 1994;269:4005-11.
19. Mould AP, Askari JA, Craig SE, Gamut AN, Clements J, Humphries MJ: Integrin α4ß1-mediated melanoma cell adhesion and migration on vascular cell adhesion molecule-1 (VCAM-1) and the alternatively spliced IIICS region of fibronectin. J Biol Chem 1994;269:27224-30.
20. Kamata T, Puzon W, Takada Y: Identification of putative ligand-binding sites of the integrin alpha 4 beta 1 (VLA-4, CD49d/CD29). Biochem J 1995;305:945-51.
21. May MJ, Entwhistle G, Humphries MJ, Ager A: VCAM-1 is a CS-1 peptide-inhabitable adhesion molecule expressed by lymph node high endothelium. J Cell Sci 1993;106:109-19.
22. Morales-Ducret J, Wayner E, Elices MJ, Alvaro-Gracia JM, Zvaifler NJ, Firestein GS: Alpha-4/beta 1 integrin (VLA-4) ligands in arthritis. I. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes. J Immunol 1992;149:1424-31.
23. Marlor CW, Webb DI, Bombara MP, Greve JM, Blue ML: Expression of vascular cell adhesion molecule-1 in fibroblast-like synoviocytes after stimulation with tumor necrosis factor. Am J Pathol 1992;140:1055-60.
24. Van Dinther-Janssen AC, Kraal G, van Soesbergen RM, Scheper RJ, Meijer CJ: Immunohistological and functional analysis of adhesion molecule expression in the rheumatoid synovial lining layer. Implications for synovial lining cell destruction. J Rheumatol 1994;21:1998-2004.
25. Kriegsmann J, Keyszer GM, Geiler T, Bräuer R, Gay RE, Gay S: Expression of vascular cell adhesion molecule-1 mRNA and protein in rheumatoid arthritis synovium demonstrated by in situ hybridization and immunohistochemistry. Lab Invest 1995;72:209-13.
26. Humphries MJ, Akiyama SK, Komoriya A, Olden K, Yamada KM: Identification of an alternatively spliced site in human plasma fibronectin that mediates cell type-specific adhesion. J Cell Biol 1986;103:2637-47.
27. Elices MJ, Tsai V, Strahl D, et al: Expression and functional significance of alternatively spliced CS-1 fibronectin in rheumatoid arthritis microvasculature. J Clin Invest 1994;93:405-16.
28. Koch AE, Burrows JC, Haines GK, Carlos TM, Harlan JM, Leibovich SJ: Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues. Lab Invest 1991;64:313-20.
29. Van Dinther-Janssen AC, Pals ST, Scheper RJ, Meijer CJ: Role of the CS1 adhesion motif of fibronectin in T cell adhesion to synovial membrane and peripheral lymph node endothelium. Ann Rheum Dis 1993;52:1998-2004.
30. Masumoto A, Hemler ME: Multiple activation states of VLA-4. Mechanistic differences between adhesion to CS1/fibronectin and to vascular cell adhesion molecule-1. J Biol Chem 1993;268:228-34.
31. ffrench-Constant C, Van De Water L, Dvorak HF, Hynes RO: Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol 1989;109:903-14.
32. Magnuson VL, Young M, Schattenberg DG, et al: The alternative splicing of fibronectin pre-mRNA is altered during aging and in response to growth factors. J Biol Chem 1991;266:14654-62.
33. Arnett FC, Edworthy SM, Bloch DA, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
34. 35S-and digoxigenin-labeled RNA and oligonucleotide probes for in situ hybridization. Histochemistry 1992;98:217-28.
35. Kornblihtt AR, Vibe-Pedersen K, Baralle FE: Human fibronectin: Cell specific alternative mRNA splicing generates polypeptide chains differing in the number of internal repeats. Nucleic Acids Res 1984;12:5853-68.
36. Gay S, Fine JD: Characterization and isolation of poly-and monoclonal antibodies against collagen for use in immunohistochemistry. Methods Enzymol 1987;145:148-67.
37. Alvaro-Gracia JM, Zvaifler NJ, Firestein GS: Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between IFN-gamma and TNF-alpha on HLA-DR expression, proliferation, collagenase production, and GM-CSF production by rheumatoid arthritis synoviocytes. J Clin Invest 1990;86:1790-8.
38. Clements JM, Newham P, Shephard M, et al: Identification of a key integrin-binding sequence in VCAM-1 homologous to the LDV active site in fibronectin. J Cell Sci 1994;107:2127-35.
39. Osborn L, Vassallo C, Griffiths-Browning B, et al: Arrangement of domains, amino acid residues required for the binding of vascular cell adhesion molecule-1 to its counter-receptor VLA-4 (α4ß1). J Cell Biol 1994;124:601-8.
40. Renz ME, Chiu HH, Jones S, et al: Structural requirements for adhesion of soluble recombinant murine vascular cell adhesion molecule-1 to α4ß1. J Cell Biol 1994;125:1395-406.
41. Vonderheide RH, Tedder TF, Springer TA, Staunton DE: Residues within a conserved amino acid motif of domains 1 and 4 of VCAM-1 are required for binding to VLA-4. J Cell Biol 1994;125:215-22.
42. Wang JH, Pepinsky RB, Stehle T, et al: The crystal structure of an N-terminal two-domain fragment of vascular cell adhesion 1 (VCAM-1); a cyclic peptide based on the domain 1 C-D loop that can inhibit VCAM-1-α4 integrin interaction. Proc Natl Acad Sci USA 1995;92:5714-8.
43. Komoriya A, Green LJ, Mervic M, Yamada SS, Yamada KM, Humphries MJ: The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine. J Biol Chem 1991;266:15075-9.
44. Wayner EA, Kovach KA: Activation-dependent recognition by hematopoietic cells of the LDV sequence in the V region of fibronectin. J Cell Biol 1992;116:489-97.
45. Laffon A, Garcia-Vicuña R, Humbria A, et al: Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis. J Clin Invest 1991;88:546-52.
46. Van Dinther-Janssen ACHM, Horst E, Koopman G, et al: The VLA-4/VCAM-1 pathway is involved in lymphocyte adhesion to endothelium in rheumatoid synovium. J Immunol 1991;147:4207-10.
47. Postigo AA, Garcia-Vicuña R, Diaz-Gonzalez F, et al: Increased binding of synovial T lymphocytes from rheumatoid arthritis to endothelial-leukocyte adhesion molecule-1 (ELAM-1) and vascular cell adhesion molecule-1 (VCAM-1). J Clin Invest 1992;89:1445-52.
48. Wahl SM, Allen JB, Hines KL, et al: Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment. J Clin Invest 1994;94:655-62.
49. Molossi S, Elices MJ, Arrhenius T, Diaz R, Coulber C, Rabinovitch M: Blockade of very late antigen-4 integrin binding to fibronectin with connecting segment-1 peptide reduces accelerated coronary arteriopathy in rabbit cardiac allografts. J Clin Invest 1995;95:2601-10.